FDA
-
-
-
-
-
-
-
PureTech Health: Results of Annual General Meeting
-
-
-
-
-
-
-
Seaport Therapeutics appoints Dr. Sharon Mates to board of directors
-
-
-
-
-
-
-
Seaport Therapeutics reports positive phase 1 results for anxiety drug
-
-
-
-
-
-
-
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Gallop Oncology to present AML trial data at ASH meeting
-
-
-
-
-
-
-
PureTech Health plc – Half-Year Report
-
-
-
-
-
-
-
PureTech launches Celea Therapeutics for respiratory disease treatments
-
325,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

